News Results
There are 989,865 News Results
Nov 1, 2018
WASHINGTON, Nov. 1, 2018 /PRNewswire/ -- Blackboard Inc. today announced new features and enhancements for Blackboard Learn with the Ultra experience. The company's feature-rich, cloud-based learning management system is seeing...
Nov 6, 2018
SAN DIEGO, Nov. 6, 2018 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced three presentations of updated clinical and preclinical data at the Society...
Nov 19, 2018
HOLLAND, Ohio, Nov. 19, 2018 /PRNewswire/ -- hoopla digital ( hoopladigital.com ), the category-creating mobile and online service for public libraries, is now offering a new book club resource that...
Nov 27, 2018
HOUSTON, Nov. 27, 2018 /PRNewswire/ -- Marker Therapeutics, Inc. (NASDAQ: MRKR), a clinical-stage immuno-oncology company, today announced the appointment of Anthony H. Kim as its new Chief Financial Officer. Michael...
Nov 27, 2018
BOSTON, Nov. 27, 2018 /PRNewswire/ -- Constant Pharmaceuticals today announced that it plans to begin a development program for its compound, TXA127, for the treatment of the rare pediatric disease,...
Dec 6, 2018
DURHAM, N.C., Dec. 6, 2018 /PRNewswire/ -- Today, the North Carolina School of Science and Mathematics (NCSSM), a public residential and online high school, announced that an alumnus has donated...
Dec 10, 2018
SHANGHAI and OXFORD, the United Kindom, Dec. 10, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and...
Dec 11, 2018
New grant offers awards of more than $1.2 million to advance uses of artificial intelligence in scientific exploration and research on critical environmental challenges
Dec 11, 2018
NW Bio Announces Non-Dilutive Funding of Approximately $47.3 Million Through UK Property Transaction
BETHESDA, Md., Dec. 11, 2018 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) -- ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that it...
Dec 17, 2018
NEW YORK, Dec. 17, 2018 /PRNewswire/ -- Neurotrope Inc. (NASDAQ:NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), today announced that data from its...
